financetom
Business
financetom
/
Business
/
Commodities trader BB Energy lays off some Houston traders in major reorganization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commodities trader BB Energy lays off some Houston traders in major reorganization
Nov 24, 2025 10:38 AM

NEW YORK (Reuters) -Commodities trader BB Energy has laid off over a dozen people from its Houston office, including oil traders, in a major restructuring of its operations, sources familiar with the matter said.

A BB Energy spokesperson confirmed that it had made changes to sharpen its focus on the most profitable areas of its core business, while diversifying into high-potential new markets. The company did not say how many employees were impacted by the changes.

"To strengthen our position in the U.S., we have begun implementing a comprehensive reorganisation designed to enhance financial resilience and improve commercial and operational efficiency," the spokesperson said.

BB Energy, which also has trading offices in UAE, UK, Singapore, Switzerland and Belgium, plans to shift some administrative functions away from the U.S. and move oversight of those responsibilities to Europe, two sources told Reuters.

The company declined to comment on how it carries out administrative functions across the group.

TRADERS LEAVE FIRM

Among the traders let go as part of the reorganization were Alexander George and Dylan Laurin, the spokesperson said. Both George and Laurin were on the crude oil desk, sources said.

George and Laurin have accepted roles at other companies, sources told Reuters.

BB Energy also laid off Trevor Plath, who focused on renewable fuels and carbon markets, three sources said.

Two distillate fuel traders, Brendan Donahue and Nelson Rios Requena, also left the firm in recent weeks, two sources told Reuters.

Bloomberg earlier reported BB Energy had lost half of its Houston traders amid a tough oil market.

BB Energy ranks among the top global commodities trading houses, with revenue of about $23 billion last year and trading volumes of about 33 million tons of crude and petroleum products, according to its website.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sylvamo's Q3 Adjusted Operating Earnings, Net Sales Rise
Sylvamo's Q3 Adjusted Operating Earnings, Net Sales Rise
Nov 12, 2024
07:56 AM EST, 11/12/2024 (MT Newswires) -- Sylvamo ( SLVM ) reported Q3 adjusted operating earnings Tuesday of $2.44 per diluted share, up from $1.70 a year earlier. Three analysts polled by Capital IQ expected $2.18. Net sales for the quarter ended Sept. 30 were $965 million, up from $897 million a year earlier. Three analysts surveyed by Capital IQ...
Shopify Up 14% at Fresh 52 Week High Levels As Q3 Revenues Beat Forecast; Sets Q4 Revenue Outlook
Shopify Up 14% at Fresh 52 Week High Levels As Q3 Revenues Beat Forecast; Sets Q4 Revenue Outlook
Nov 12, 2024
07:58 AM EST, 11/12/2024 (MT Newswires) -- Shopify ( SHOP ) was at last look up 14% and at fresh 52 week high levels in US prmarket trade after reporting Q3 revenue Tuesday of US$2.16 billion, up from $1.71 billion a year earlier. Analysts surveyed by Capital IQ expected $2.11 billion. The company said it expects Q4 revenue to grow...
Wave Life Sciences Swings to Q3 Loss
Wave Life Sciences Swings to Q3 Loss
Nov 12, 2024
08:14 AM EST, 11/12/2024 (MT Newswires) -- Wave Life Sciences ( WVE ) reported a Q3 loss Tuesday of $0.47 per diluted share, swinging from earnings of $0.07 a year earlier. Analysts polled by Capital IQ expected a loss of $0.29. The company reported no revenue for the quarter ended Sept. 30 compared with $49.2 million a year earlier. Analysts...
BridgeBio Pharma's Q3 Loss Narrows, Revenue Declines
BridgeBio Pharma's Q3 Loss Narrows, Revenue Declines
Nov 12, 2024
07:58 AM EST, 11/12/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q3 loss Tuesday of $0.86 per diluted share, narrowing from a loss of $1.08 a year earlier. Three analysts surveyed by Capital IQ expected a loss of $0.98. Revenue for the quarter ended Sept. 30 was $2.7 million, down from $4.1 million a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved